# AdvanDx

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/advandx

- Industry: Healthcare
- Headquarters: Woburn, US
- Website: www.advandx.com
- Total disclosed funding: $37M
- Latest round: Series B (Apr 8, 2014)
- Investors on record: 4

## About

AdvanDx is based in US and operates as a diagnostics firm which provides molecular diagnostic tests for identification of pathogens causing critical infections in hospitalized patients.

## Funding rounds

- Series B, Apr 8, 2014, $12M — LD Pensions, SLS Invest, Merck Global Health Innovation Fund
- Series D, Oct 25, 2012, $2.2M — SLS Invest
- Series C, Aug 18, 2009, $8M — LD Pensions, SLS Invest
- Series C, Sep 18, 2007, $15M — LD Pensions, SLS Invest, bioMérieux

## Investors

- LD Pensions — Series C, Series B
- SLS Invest (https://capitalatlas.ai/funds/sls-invest) — Series C, Series D, Series B
- bioMérieux — Series C
- Merck Global Health Innovation Fund (https://capitalatlas.ai/funds/merck-global-health-innovation-fund) — Series B